Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at Jefferies: SUCCESSOR-2 interim validates CELMoD strategy
Go back to Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at Jefferies: SUCCESSOR-2 interim validates CELMoD strategy| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 59.12 -0.46 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.58 | 52 Week High | $77.12 | |||
| Open | $58.88 | 52 Week Low | $49.03 | |||
| Day High | $59.79 | P/E | 38.39 | |||
| Day Low | $58.74 | EPS | $1.54 | |||
| Volume | 9,253,469 | |||||



